The Insignia-PAH Clinical Trial

  • Home
  • The Insignia-PAH Clinical Trial

The Insignia-PAH Clinical Trial The INSIGNIA-PAH Clinical Trial will test an investigational drug in adults ages 18 to 75 who have pulmonary arterial hypertension (PAH).

This page is intended for a United States audience only. Sponsored by Merck & Co., Inc.

Address


Website

Alerts

Be the first to know and let us send you an email when The Insignia-PAH Clinical Trial posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

  • Address
  • Alerts
  • Claim ownership or report listing

  • Want your practice to be the top-listed Clinic?

Share